Brown Advisory Inc. reduced its stake in McKesson Co. (NYSE:MCK) by 6.0% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,849 shares of the company’s stock after selling 245 shares during the quarter. Brown Advisory Inc.’s holdings in McKesson were worth $425,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors and hedge funds also recently made changes to their positions in MCK. Oregon Public Employees Retirement Fund raised its stake in McKesson by 8,651.1% in the fourth quarter. Oregon Public Employees Retirement Fund now owns 8,416,267 shares of the company’s stock valued at $76,000 after purchasing an additional 8,320,093 shares in the last quarter. Nordea Investment Management AB raised its stake in shares of McKesson by 48.8% during the third quarter. Nordea Investment Management AB now owns 3,300,839 shares of the company’s stock worth $437,856,000 after acquiring an additional 1,082,398 shares in the last quarter. Matthew Goff Investment Advisor LLC raised its stake in shares of McKesson by 13,239.1% during the third quarter. Matthew Goff Investment Advisor LLC now owns 987,361 shares of the company’s stock worth $7,402,000 after acquiring an additional 979,959 shares in the last quarter. Renaissance Technologies LLC purchased a new position in shares of McKesson during the third quarter worth approximately $92,775,000. Finally, Rehmann Capital Advisory Group raised its stake in shares of McKesson by 14,640.7% during the third quarter. Rehmann Capital Advisory Group now owns 594,049 shares of the company’s stock worth $4,478,000 after acquiring an additional 590,019 shares in the last quarter. 86.55% of the stock is currently owned by institutional investors and hedge funds.

Shares of McKesson stock opened at $115.65 on Tuesday. The company has a current ratio of 1.02, a quick ratio of 0.57 and a debt-to-equity ratio of 0.81. McKesson Co. has a 52-week low of $106.11 and a 52-week high of $160.84. The company has a market capitalization of $22.74 billion, a PE ratio of 9.16, a PEG ratio of 1.24 and a beta of 1.25.

McKesson (NYSE:MCK) last issued its earnings results on Thursday, January 31st. The company reported $3.40 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.18 by $0.22. McKesson had a negative net margin of 0.15% and a positive return on equity of 27.83%. The firm had revenue of $56.21 billion for the quarter, compared to analysts’ expectations of $55.27 billion. During the same quarter last year, the business earned $3.41 earnings per share. As a group, analysts predict that McKesson Co. will post 13.53 EPS for the current year.

The company also recently announced a quarterly dividend, which will be paid on Monday, April 1st. Stockholders of record on Friday, March 1st will be issued a $0.39 dividend. This represents a $1.56 annualized dividend and a dividend yield of 1.35%. The ex-dividend date is Thursday, February 28th. McKesson’s dividend payout ratio is 12.36%.

In other news, EVP Lori A. Schechter sold 7,700 shares of the firm’s stock in a transaction that occurred on Wednesday, January 16th. The shares were sold at an average price of $122.96, for a total value of $946,792.00. Following the transaction, the executive vice president now owns 10,000 shares in the company, valued at $1,229,600. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.87% of the stock is currently owned by company insiders.

MCK has been the topic of several research reports. Morgan Stanley decreased their price target on shares of McKesson from $142.00 to $130.00 in a research note on Sunday, December 9th. Zacks Investment Research raised shares of McKesson from a “hold” rating to a “buy” rating and set a $144.00 price target on the stock in a research note on Monday, February 4th. Barclays reissued a “hold” rating and set a $124.00 price target on shares of McKesson in a research note on Sunday, January 6th. Deutsche Bank raised shares of McKesson from a “sell” rating to a “hold” rating and set a $175.00 price target on the stock in a research note on Friday, January 25th. Finally, UBS Group initiated coverage on shares of McKesson in a research note on Thursday, January 17th. They set a “neutral” rating and a $134.00 price target on the stock. One investment analyst has rated the stock with a sell rating, eight have assigned a hold rating and six have issued a buy rating to the stock. The company currently has a consensus rating of “Hold” and a consensus price target of $137.99.

COPYRIGHT VIOLATION WARNING: “McKesson Co. (MCK) Position Trimmed by Brown Advisory Inc.” was originally posted by Watch List News and is the property of of Watch List News. If you are reading this article on another domain, it was illegally copied and republished in violation of United States and international copyright law. The legal version of this article can be accessed at https://www.watchlistnews.com/mckesson-co-mck-position-trimmed-by-brown-advisory-inc/2918133.html.

McKesson Company Profile

McKesson Corporation provides pharmaceuticals and medical supplies in the United States and internationally. It operates in three segments: U.S. Pharmaceutical and Specialty Solutions, European Pharmaceutical Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs, as well as other healthcare-related products; and offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices.

Further Reading: What is a Roth IRA?

Want to see what other hedge funds are holding MCK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for McKesson Co. (NYSE:MCK).

Institutional Ownership by Quarter for McKesson (NYSE:MCK)

Receive News & Ratings for McKesson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson and related companies with MarketBeat.com's FREE daily email newsletter.